Literature DB >> 20859796

Xanthines as adenosine receptor antagonists.

Christa E Müller1, Kenneth A Jacobson.   

Abstract

The natural plant alkaloids caffeine and theophylline were the first adenosine receptor (AR) antagonists described in the literature. They exhibit micromolar affinities and are non-selective. A large number of derivatives and analogues were subsequently synthesized and evaluated as AR antagonists. Very potent antagonists have thus been developed with selectivity for each of the four AR subtypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20859796      PMCID: PMC3882893          DOI: 10.1007/978-3-642-13443-2_6

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  217 in total

1.  [(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.

Authors:  X D Ji; G L Stiles; K A Jacobson
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

2.  Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

Authors:  Keita Ishiwari; Lisa J Madson; Andrew M Farrar; Susana M Mingote; John P Valenta; Michael D DiGianvittorio; Lauren E Frank; Merce Correa; Jörg Hockemeyer; Christa Müller; John D Salamone
Journal:  Behav Brain Res       Date:  2006-12-21       Impact factor: 3.332

Review 3.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

4.  Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.

Authors:  Marcus H Holschbach; Ray A Olsson; Dirk Bier; Walter Wutz; Wiebke Sihver; Manfred Schüller; Bettina Palm; Heinz H Coenen
Journal:  J Med Chem       Date:  2002-11-07       Impact factor: 7.446

5.  Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Authors:  Charles W Schindler; Marzena Karcz-Kubicha; Eric B Thorndike; Christa E Müller; Srihari R Tella; Sergi Ferré; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

6.  Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.

Authors:  W Hauber; P Neuscheler; J Nagel; C E Müller
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

7.  Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.

Authors:  M T Shamim; D Ukena; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1989-06       Impact factor: 7.446

8.  2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.

Authors:  Vita Ozola; Mark Thorand; Martina Diekmann; Ramatullah Qurishi; Britta Schumacher; Kenneth A Jacobson; Christa E Müller
Journal:  Bioorg Med Chem       Date:  2003-02-06       Impact factor: 3.641

Review 9.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

10.  Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.

Authors:  K A Jacobson; S Barone; U Kammula; G L Stiles
Journal:  J Med Chem       Date:  1989-05       Impact factor: 7.446

View more
  36 in total

Review 1.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 2.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

Review 3.  Treatment options for Cheyne-Stokes respiration and heart failure.

Authors:  Shigetake Sasayama
Journal:  Curr Heart Fail Rep       Date:  2011-09

4.  Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.

Authors:  Andrew S Doré; Nathan Robertson; James C Errey; Irene Ng; Kaspar Hollenstein; Ben Tehan; Edward Hurrell; Kirstie Bennett; Miles Congreve; Francesca Magnani; Christopher G Tate; Malcolm Weir; Fiona H Marshall
Journal:  Structure       Date:  2011-09-07       Impact factor: 5.006

5.  A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Authors:  C Laurent; S Burnouf; B Ferry; V L Batalha; J E Coelho; Y Baqi; E Malik; E Mariciniak; S Parrot; A Van der Jeugd; E Faivre; V Flaten; C Ledent; R D'Hooge; N Sergeant; M Hamdane; S Humez; C E Müller; L V Lopes; L Buée; D Blum
Journal:  Mol Psychiatry       Date:  2014-12-02       Impact factor: 15.992

6.  Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.

Authors:  Mohamad Wessam Alnouri; Stephan Jepards; Alessandro Casari; Anke C Schiedel; Sonja Hinz; Christa E Müller
Journal:  Purinergic Signal       Date:  2015-07-01       Impact factor: 3.765

7.  Regulation of photoreceptor gap junction phosphorylation by adenosine in zebrafish retina.

Authors:  Hongyan Li; Alice Z Chuang; John O'Brien
Journal:  Vis Neurosci       Date:  2014-05       Impact factor: 3.241

Review 8.  A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.

Authors:  Stephen M Hatfield; Michail Sitkovsky
Journal:  Curr Opin Pharmacol       Date:  2016-07-17       Impact factor: 5.547

9.  Stimulatory Effects of KPR-A148 on Osteoblast Differentiation and Bone Regeneration.

Authors:  Soomin Lim; Ju Ang Kim; Taeho Lee; Jiwon Lim; Doohyun Lee; Sang-Hyeon Nam; Eui Kyun Park
Journal:  Tissue Eng Regen Med       Date:  2019-07-17       Impact factor: 4.169

10.  GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.

Authors:  Angela Kecskés; Dilip K Tosh; Qiang Wei; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2011-05-12       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.